1351-GABA Inhibition of TLS in Cancer Immunotherapy
Research investigates why certain tumors fail to respond to immunotherapy despite the presence of protective tertiary lymphoid structures. The study identifies that cancer cells can produce GABA, a chemical that acts as an immunosuppressant to disable nearby immune cells. High levels of this substance lead to dysfunctional B cells and reduced antibody production, creating an environment where the cancer can thrive. By inhibiting GABA in combination with standard treatments, researchers found they could restore immune function and significantly slow tumor growth. These findings suggest that…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.